U.S. Physical Therapy, Inc.
USPH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.59 | -1.23 | 0.51 | 1.35 |
| FCF Yield | 1.21% | 2.66% | -0.66% | 1.27% |
| EV / EBITDA | 45.57 | 46.89 | 53.51 | 61.03 |
| Quality | ||||
| ROIC | 1.33% | 1.76% | 1.38% | 0.90% |
| Gross Margin | 22.48% | 25.35% | 20.36% | 18.67% |
| Cash Conversion Ratio | 1.13 | 1.97 | -0.47 | 1.55 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.80% | 4.63% | 5.45% | 6.67% |
| Free Cash Flow Growth | -50.57% | 535.76% | -142.87% | -13.66% |
| Safety | ||||
| Net Debt / EBITDA | 4.06 | 8.71 | 10.53 | 9.74 |
| Interest Coverage | 8.08 | 10.30 | 8.62 | 7.10 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 31.86 | 48.11 | 49.12 | 39.09 |